Bajaj Holdings & Investments Ltd. v. Assessee

ITA No. 7237/Mum/2008

The appeal challenged the assessment order upholding that payments made by Bajaj Holdings & Investments Ltd. to Xennia Technology Ltd. for developing inkjet printers and inks were royalty/fees for technical services, subject to TDS at 15%. The Tribunal examined the agreement and found it involved technology transfer and IP ownership rights, thus confirming the payment was not merely a purchase of machinery.

Jurisdiction
India
Court
Income Tax Appellate Tribunal - Mumbai
Case Number
ITA No. 7237/Mum/2008
Decision Date
10 January 2013

Practitioner Note

This decision partly_allowed relief to the petitioner. If you are facing a similar patent dispute before Income Tax Appellate Tribunal - Mumbai, this precedent supports interim or final relief where the facts are comparable. The ratio regarding the applied tests is particularly relevant for strategy.

Related Cases

patentWrit Petition No. 17241 of 2014

Fdc Ltd.vsUnion Of India

FDC Ltd. challenged an order passed by the Intellectual Property Appellate Board (IPAB) which had set aside the Assistant Controller's initial ruling against the petitioner regarding the revocation of Indian Patent No.197822. The core dispute centered on whether IPAB should have decided the merits or remanded the matter, and specifically, whether directing a fresh Opposition Board was legally sound.

patentC.A.(COMM.IPD-PAT) 275/2022

Qualcomm IncorporatedvsController Of Patents And Others

Qualcomm appealed a decision by the Deputy Controller of Patents which rejected their patent application (No. 5159/DELNP/2007) primarily citing Section 3(k) and lack of definitiveness. The High Court found that the rejection order suffered from manifest non-application of mind as it failed to address the appellant's submissions, leading to the setting aside of the impugned order.

patentCS(COMM) 343/2019 & I.As. 8878/2019

Bayer Healthcare LlcvsNatco Pharma Limited

Bayer Healthcare LLC sought an interim injunction against Natco Pharma Limited regarding the patented anti-cancer drug, REGORAFENIB. The Delhi High Court examined the plaintiff's claim, noting that while the patent was validly granted, the plaintiff failed to establish a prima facie case for injunction. Crucially, the court considered the public interest, highlighting the significant price disparity between Bayer's imported product and Natco's domestically manufactured, affordable version.

patentC.A.(COMM.IPD-PAT) 167/2022

Adama Makhteshim LtdvsThe Controller Of Patents

Adama Makhteshim Ltd appealed the refusal of its patent application (No. 201617025525) by the Controller of Patents, which was based on lack of inventive step and clarity/sufficiency of disclosure. The Court found that procedural irregularities vitiated the impugned order because it failed to address all grounds of objection raised in the Hearing Notice.

patent(T)CMA(TM)/105 /2023

Japan Tobacco Inc.vsThe Assistant Controller of Patents and Designs, Government of India, Patent Office

Japan Tobacco Inc. filed a Transfer Civil Miscellaneous Appeal seeking to set aside an earlier order and allow its patent application (No. 6844/CHENP/2010) to proceed for grant. The appellant subsequently moved for withdrawal of the appeal.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call